PuSH - Publikationsserver des Helmholtz Zentrums München

Bach, C.E. ; Gilch, S.* ; Rost, R.* ; Greenwood, A.D. ; Horsch, M. ; Hajj,G.N.M.* ; Brodesser, S.* ; Facius, A. ; Schädler, S. ; Sandhoff, K.* ; Beckers, J. ; Leib-Mösch, C. ; Schatzl, H.M.* ; Vorberg, I.*

Prion-induced activation of cholesterogenic gene expression by Srebp2 in neuronal cells.

J. Biol. Chem. 284, 31260-31269 (2009)
Verlagsversion DOI PMC
Open Access Gold
Prion diseases are neurodegenerative diseases associated with the accumulation of a pathogenic isoform of the host-encoded prion protein. The cellular responses to prion infection are not well defined. By performing microarray analysis on cultured neuronal cells infected with prion strain 22L, in the group of up-regulated genes we observed predominantly genes of the cholesterol pathway. Increased transcript levels of at least nine enzymes involved in cholesterol synthesis, including the gene for the rate-limiting hydroxymethylglutaryl-CoA reductase, were detected. Up-regulation of cholesterogenic genes was attributable to a prion-dependent increase in the amount and activity of the sterol regulatory element-binding protein Srebp2, resulting in elevated levels of total and free cellular cholesterol. The up-regulation of cholesterol biosynthesis appeared to be a characteristic response of neurons to prion challenge, as cholesterogenic transcripts were also elevated in persistently infected GT-1 cells and prion-exposed primary hippocampal neurons but not in microglial cells and primary astrocytes. These results convincingly demonstrate that prion propagation not only depends on the availability of cholesterol but that neuronal cells themselves respond to prions with specific up-regulation of cholesterol biosynthesis.
Impact Factor
Scopus SNIP
Web of Science
Times Cited
Scopus
Cited By
Altmetric
5.520
2.120
22
30
Tags
Anmerkungen
Besondere Publikation
Auf Hompepage verbergern

Zusatzinfos bearbeiten
Eigene Tags bearbeiten
Privat
Eigene Anmerkung bearbeiten
Privat
Auf Publikationslisten für
Homepage nicht anzeigen
Als besondere Publikation
markieren
Publikationstyp Artikel: Journalartikel
Dokumenttyp Wissenschaftlicher Artikel
Sprache englisch
Veröffentlichungsjahr 2009
HGF-Berichtsjahr 0
ISSN (print) / ISBN 0021-9258
e-ISSN 1083-351X
Quellenangaben Band: 284, Heft: 45, Seiten: 31260-31269 Artikelnummer: , Supplement: ,
Verlag American Society for Biochemistry and Molecular Biology
Verlagsort Bethesda
Begutachtungsstatus Peer reviewed
POF Topic(s) 30203 - Molecular Targets and Therapies
30201 - Metabolic Health
30505 - New Technologies for Biomedical Discoveries
Forschungsfeld(er) Immune Response and Infection
Genetics and Epidemiology
Enabling and Novel Technologies
PSP-Element(e) G-502700-001
G-500600-004
G-503700-001
PubMed ID 19748890
Scopus ID 71449102371
Erfassungsdatum 2009-11-27